EGFR and non-small cell lung carcinoma: These online repositories afford simultaneous access to expression data for a multitude of genes, which can be meticulously analyzed to unearth prospective biomarkers and therapeutic targets implicated in EGFR–TKI drug resistance in NSCLC.